Scarica l'app Stockscreener
1.26
1.61%
0.02
Pre-mercato:
1.26
Precedente Chiudi:
$1.24
Aprire:
$1.25
Volume 24 ore:
46,787
Relative Volume:
0.50
Capitalizzazione di mercato:
$2.24M
Reddito:
$770.00K
Utile/perdita netta:
$-38.84M
Rapporto P/E:
-0.0887
EPS:
-14.2049
Flusso di cassa netto:
$-43.02M
1 W Prestazione:
-10.00%
1M Prestazione:
-33.16%
6M Prestazione:
-82.10%
1 anno Prestazione:
-86.15%
Intervallo 1D:
$1.225
$1.35
Intervallo di 1 settimana:
$0.9062
$1.46
Portata 52W:
$0.9062
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
Nome
Lyra Therapeutics Inc
Settore
Industria
Telefono
617-373-4600
Indirizzo
480 ARSENAL WAY, WATERTOWN, MA
Compare LYRA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
1.26 | 2.20M | 770.00K | -38.84M | -43.02M | -14.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-07 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-05-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-05-07 | Downgrade | Jefferies | Buy → Hold |
| 2024-05-06 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-10-06 | Ripresa | BTIG Research | Buy |
| 2023-08-31 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-05-26 | Iniziato | BTIG Research | Buy |
| 2020-05-26 | Iniziato | BofA/Merrill | Buy |
| 2020-05-26 | Iniziato | Jefferies | Buy |
| 2020-05-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Lyra Therapeutics Inc Borsa (LYRA) Ultime notizie
Growth Review: Will Lyra Therapeutics Inc be affected by tariffsJuly 2025 Earnings & Technical Confirmation Trade Alerts - baoquankhu1.vn
LYRA Technical Analysis & ETF Price Forecast - Intellectia AI
Lyra Therapeutics to Present at Upcoming Investor Conferences - PR Newswire
Lyra Therapeutics receives default notice for unpaid rent as wind-down continues - Investing.com India
LYRA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
LYRA Technical Analysis & Stock Price Forecast - Intellectia AI
Lyra Therapeutics receives default notice for unpaid rent as wind-down continues By Investing.com - Investing.com South Africa
LYRA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Lyra Therapeutics (LYRA) hit with sublease default as it winds down - Stock Titan
LYRA Should I Buy - Intellectia AI
Short Covering: What are the risks of holding Lyra Therapeutics IncWeekly Market Outlook & AI Powered Market Entry Ideas - baoquankhu1.vn
LYRA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Will Lyra Therapeutics Inc be affected by tariffs2025 Institutional Moves & Daily Market Momentum Tracking - baoquankhu1.vn
Pullback Watch: Is Lyra Therapeutics Inc stock a good pick for beginnersJuly 2025 Earnings & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Stock Report: What is Lyra Therapeutics Incs P E ratio telling usWeekly Trade Analysis & Verified Short-Term Trading Plans - baoquankhu1.vn
Quarterly Risk: Will Lyra Therapeutics Inc be affected by tariffs2025 Analyst Calls & Risk Controlled Daily Plans - baoquankhu1.vn
Can Lyra Therapeutics Inc. outperform under higher oil pricesQuarterly Portfolio Report & Safe Capital Investment Plans - mfd.ru
What are the analyst revisions for Lyra Therapeutics Inc.Is BBAR stock a good investment in YEARTrade Entry Report & Daily Profit Focused Stock Screening - mfd.ru
Is Lyra Therapeutics Inc. stock vulnerable to regulatory risksWeekly Trading Summary & Consistent Growth Stock Picks - mfd.ru
Analyst Upgrade: How much upside does Lyra Therapeutics Inc haveJuly 2025 Short Interest & Weekly High Return Stock Opportunities - baoquankhu1.vn
Lyra Therapeutics Faces Nasdaq Delisting Battle After Clinical Setback - AD HOC NEWS
Lyra Therapeutics Faces Nasdaq Delisting After Becoming Shell - The Globe and Mail
Lyra Therapeutics (LYRA) Faces Nasdaq Delisting - GuruFocus
Lyra Therapeutics Faces Nasdaq Delisting Over Shell Company Concerns, Capital Shortfall - marketscreener.com
Lyra Therapeutics Received Notice of Delisting - TradingView
Nasdaq plans to delist Lyra Therapeutics (LYRA) after shell status finding - Stock Titan
What is the dividend yield of Lyra Therapeutics IncMarket Risk Analysis & Risk Managed Investment Strategies - baoquankhu1.vn
Aug Sectors: Can Lyra Therapeutics Inc grow without external funding2025 Performance Recap & Capital Efficiency Focused Ideas - baoquankhu1.vn
Why hedge funds are buying Lyra Therapeutics Inc. stockJuly 2025 Drop Watch & Safe Capital Growth Trade Ideas - mfd.ru
What is the dividend yield of Lyra Therapeutics Inc.July 2025 EndofMonth & Verified Swing Trading Watchlist - mfd.ru
Should I buy Lyra Therapeutics Inc. stock nowWeekly Profit Summary & Weekly Setup with High ROI Potential - mfd.ru
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Downgrade Watch: Will Lyra Therapeutics Inc benefit from green energy policies2025 Retail Activity & Consistent Income Trade Recommendations - baoquankhu1.vn
How Lyra Therapeutics Inc. stock reacts to Fed rate cutsFederal Reserve Announcements & Fast Growing Portfolio Trading - bollywoodhelpline.com
How cyclical is Lyra Therapeutics Inc.’s revenue streamPortfolio Performance Summary & Accurate Intraday Trading Signals - Bollywood Helpline
Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch - RTTNews
Aug Spikes: Is Lyra Therapeutics Inc stock a good pick for beginnersJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn
Bearish Setup: Will Cheniere Energy Inc stock hit new highs in YEARWeekly Loss Report & Safe Entry Point Identification - baoquankhu1.vn
Layoff Tracker: Lyra Shutters, EMD Serono Downsizes - BioSpace
How much upside does Lyra Therapeutics Inc. have2025 Valuation Update & Weekly Sector Rotation Insights - Bollywood Helpline
Take Profit: Is CRTO forming bullish engulfing patternsWeekly Trade Report & Verified Technical Signals - baoquankhu1.vn
EV Market: Will Lyra Therapeutics Inc stock maintain momentum in 2025Analyst Downgrade & Weekly Return Optimization Plans - Bộ Nội Vụ
Lyra Therapeutics suspends further development of LYR-210 - Yahoo Finance
Lyra Therapeutics halts development of lead CRS treatment By Investing.com - Investing.com Nigeria
Mass. biotech company lays off entire workforce as cash dwindles - nbcboston.com
Gold Rises Sharply; Lyra Therapeutics Shares Plunge - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Watertown biotech suspends drug development and eliminates workforce as cash dwindles - The Business Journals
Lyra Therapeutics, Inc. Announces Termination of Jason Cavalier as Chief Financial Officer - marketscreener.com
LYRA Plunges 55% After Company Halts Lead Program And Begins Strategic Review - Nasdaq
Lyra Therapeutics Inc Azioni (LYRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lyra Therapeutics Inc Azioni (LYRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Cavalier Jason | Chief Financial Officer |
Jan 06 '26 |
Sale |
3.36 |
769 |
2,587 |
518,547 |
| Palasis Maria | President & CEO |
Jan 06 '26 |
Sale |
3.36 |
1,702 |
5,726 |
1,096,733 |
0.11%
6.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):